Trust & Enterprise Readiness Center
Enterprise trust starts with facts, owners, evidence, launch gates, and visible limitations.
This center is an operational readiness and claims-control register for SCRIMED's governed synthetic evaluation product. It is not legal advice, a compliance certification, a regulatory determination, or authorization for live clinical execution.
Trust is a buying advantage
SCRIMED sells confidence by showing what is proven, what is gated, and who owns the next review.
Serious healthcare buyers do not only buy features. They buy lower diligence friction, safer evaluation paths, accountable owners, and a vendor that can say no before risk crosses the line.
AI projects stall when value, ownership, and risk are unclear.
SCRIMED packages demos, pilot paths, price bands, owners, proof routes, and limitations so executives can sponsor a finite evaluation instead of an open-ended experiment.
- Executive confidence is pilot readiness, not procurement approval, production authorization, or guaranteed financial outcome.
Healthcare AI vendors often blur demos, PHI, security posture, and compliance status.
SCRIMED separates no-PHI demos, protected pilot evidence, TrustOps incidents, claims control, external review gates, and certification limits before buyer diligence begins.
- Readiness evidence is not HIPAA compliance certification, SOC 2, HITRUST, ISO certification, legal advice, or security approval.
Automation can create patient-safety risk if it looks clinical before governance is ready.
SCRIMED keeps current product language operational, synthetic, review-gated, and non-diagnostic while clinical authority, PHI, connector, and live-care gates remain explicit.
- Operational intelligence is not diagnosis, treatment guidance, patient outreach, EHR writeback, payer submission, or live clinical decision support.
Custom AI pilots become expensive, vague, and hard to evaluate.
SCRIMED aligns each buying motion to a defined assessment, synthetic pilot, protected enterprise pilot, or governance review with delivery artifacts and margin-aware boundaries.
- Pricing posture is not a binding quote, contract, revenue guarantee, ROI guarantee, reimbursement guarantee, or audited financial report.
Trust claims need to be defensible before capital, partnership, or clinic adoption conversations expand.
SCRIMED shows sellable offers, product proof, audience packets, competitive defense, limitations, and hard stops so the diligence story is credible without becoming securities material.
- Investor readiness is not investment advice, securities offering material, solicitation, valuation assurance, or legal or tax advice.
24/7 trust operations
Trust readiness becomes stronger when agents continuously watch, audit, fix, and improve.
The Trust Safety Operations layer coordinates PHI shielding, agent firewalling, copyright and IP provenance, claims control, clinical safety boundaries, security incident watch, and continuous improvement.
Readiness domains
Every company-scale obligation has an accountable owner and an explicit gate.
Readiness is not a binary badge. SCRIMED distinguishes active controls from unresolved decisions and work that must be completed with qualified external reviewers.
Legal Readiness
The product boundary and prohibited clinical claims are explicit. Final legal documents and regulatory determinations require qualified counsel.
- Owner: Founder, executive leadership, and qualified counsel
- 5 controlled requirements
- 3 prohibited action classes
Security Readiness
The application maintains synthetic-only boundaries, deny-by-default execution routes, reproducible builds, and baseline browser security headers. A formal security program and independent testing remain required.
- Owner: Security and engineering
- 4 controlled requirements
- 3 prohibited action classes
Privacy Readiness
Public product flows prohibit PHI and minimize captured data. Final notices, processing records, retention schedules, and regional assessments remain required.
- Owner: Privacy, legal, security, and product
- 4 controlled requirements
- 3 prohibited action classes
Brand Readiness
Company name, slogan, visual language, official Wix site, branded product domain, Atlas, and FaithCore boundaries are documented.
- Owner: Founder, brand leadership, and counsel
- 5 controlled requirements
- 3 prohibited action classes
AI & Enterprise Governance
Agent registry, TrustQA, Trust Cards, AI Asset Registry, audit surfaces, human approvals, deny-by-default routes, and quality gates are active for synthetic evaluation.
- Owner: Executive, clinical, security, privacy, and AI governance
- 4 controlled requirements
- 3 prohibited action classes
Marketing Readiness
Product copy consistently presents governed synthetic evaluations, operational intelligence, human review, and explicit production exclusions.
- Owner: Marketing, product, legal, and clinical governance
- 4 controlled requirements
- 3 prohibited action classes
Public Relations Readiness
The mission, product boundary, official website, founder, and approved claims are documented. Formal media and crisis processes remain to be approved.
- Owner: Founder, communications, legal, security, and governance
- 4 controlled requirements
- 3 prohibited action classes
Sales Readiness
Pricing, offers, demos, pilot programs, no-PHI intake, branded product routing, readiness brief, and proof stack are available.
- Owner: Founder, sales, product, legal, security, and privacy
- 4 controlled requirements
- 3 prohibited action classes
Advertising Readiness
Approved and prohibited claims are centralized. Paid campaign controls, substantiation packets, targeting policy, and review workflow remain required.
- Owner: Advertising, marketing, privacy, legal, and clinical governance
- 4 controlled requirements
- 3 prohibited action classes
Commercial truth
SCRIMED is sellable now within a governed synthetic evaluation boundary.
The current product supports enterprise discovery, workflow intelligence assessments, AI readiness audits, synthetic pilots, and automation blueprints. It does not authorize live PHI, autonomous care, payer submission, or production clinical execution.